Opinion|Videos|July 23, 2024
Preparation of RSV Vaccines
Focusing on the preparation of RSV vaccines, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, provides detailed insights on the differences between the adjuvanted and nonadjuvanted vaccines.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- There are currently two RSV vaccines available, adjuvanted and non-adjuvanted. How do these vaccines compare based on their indicated patient populations, preparation, dosing, and administration?
Advertisement
Related to this article
Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder that primarily affects the nervous system, causing progressive loss of muscle control and coordination.
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Most patients screened by a hospital pharmacist-led transitions-of-care service had unmet pneumococcal and other vaccine needs, and most accepted vaccination when offered.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
The FDA has approved rebisufligene etisparvovec-hopf (Fayuvi), the first treatment designed to alter the course of mucopolysaccharidosis type IIIA.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
3
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
4
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
5